Legal & General Group’s CARGO Therapeutics CRGX Stock Holding History

Legal & General Group’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,037	Closed	-$12.5K	–	3416
2025 Q2	$12.5K	Sell	3,037 -10,968	-78%	-$47K	﹤0.01%	3202
2025 Q1	$57K	Sell	14,005 -3,665	-21%	-$24.5K	﹤0.01%	2717
2024 Q4	$255K	Hold	17,670	–	–	﹤0.01%	2633
2024 Q3	$326K	Buy	17,670 +1,268	+8%	+$22.7K	﹤0.01%	2590
2024 Q2	$269K	Buy	16,402 +1,765	+12%	+$33.6K	﹤0.01%	2624
2024 Q1	$327K	Buy	14,637 +4,637	+46%	+$110K	﹤0.01%	2584
2023 Q4	$232K	Buy	+10,000	New	+$170K	﹤0.01%	2676

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's CRGX Position: Q3 2025 in Review

Legal & General Group sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 3,037 shares — an estimated $12.5K sold.

Legal & General Group first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $327K in Q1 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Legal & General Group reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Legal & General Group sold 3,037 CARGO Therapeutics shares in Q3 2025, an estimated $12.5K.
Legal & General Group first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Legal & General Group's CARGO Therapeutics position peaked at $327K in Q1 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Legal & General Group's 13F filing for Q3 2025, filed 13 Nov 2025.